Piasecki T
Z II Kliniki Chorób Psychicznych AM w Gdańsku.
Psychiatr Pol. 1996 Jan-Feb;30(1):137-50.
This paper describes therapeutic problems concerning antiparkinsonian drugs in psychiatry. Particular attention was paid to problems like: 1. Possibility of making a therapeutic mistake of too prolonged and therefore harmful pharmacotherapy with antiparkinsonian drugs in the treatment of most common psychoses. 2. The importance of a careful selection of an optimal antiparkinsonian drug, especially in psyhogeriatric cases (for example Amantadinum). 3. The description of other indications for antiparkinsonian drugs: affective diseases or alcoholic withdrawal syndroms.
本文描述了精神病学中抗帕金森病药物的治疗问题。特别关注了以下问题：1. 在治疗最常见的精神病时，使用抗帕金森病药物进行过长时间且有害的药物治疗可能会导致治疗错误。2. 谨慎选择最佳抗帕金森病药物的重要性，尤其是在老年精神病患者中（例如金刚烷胺）。3. 抗帕金森病药物的其他适应证描述：情感性疾病或酒精戒断综合征。
